High expressions of HER1 or HER2 when coexpressed with high HER3 and HER4 strongly correlated (P<0.05) with good prognostic indicators of bladder cancer (early stage of tumour (Ta–T1), low grade (Grade I/II) and papillary type of tumour). Here, ERBB3 is linked to urinary bladder cancer.